Company news
Hob Biotech Group Corp., Ltd. Class A (SSE:688656) news
Hob Biotech Group Corp., Ltd. Class A news releases on 6ix. Latest, Sep 11, 2026: "HOB BIOTECH GROUP CORP., LTD."Self-inspection Report on Trading…
Press releases & updates
"HOB BIOTECH GROUP CORP., LTD."Self-inspection Report on Trading in the Company's Shares by Insiders in Relation to the 2026 Restricted Share Incentive Plan
September 10, 2026
"HOB BIOTECH GROUP CORP., LTD."Statement and Review Opinion on the Public Disclosure of the List of Participants for the Initial Grant under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors
September 4, 2026
"HOB BIOTECH GROUP CORP., LTD."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Wholly-owned Subsidiary
September 3, 2026
"HOB BIOTECH GROUP CORP., LTD."Notice on Convening the 3rd Extraordinary General Meeting in 2026
August 25, 2026
"HOB BIOTECH GROUP CORP., LTD."Semi-annual Report for 2026
August 17, 2026
"HOB BIOTECH GROUP CORP., LTD."Announcement on Voluntary Disclosure Regarding a Wholly-Owned Subsidiary's Obtaining of a Medical Device Registration Certificate
July 15, 2026
"HOB BIOTECH GROUP CORP., LTD."Announcement on Changing Registered Capital, Amending the "Articles of Association", and Handling Industrial and Commercial Change Registration
July 3, 2026
Indicative Announcement on Termination of Person Acting in Concert Relationship by Shareholder and Changes in Equity
June 25, 2026
Announcement on Election of Employee Representative Directors for the 4th Board of Directors
June 24, 2026
Announcement on Vesting Results in the 1st Vesting Period for Category I Incentive Objects of Those Initially Granted in the 2023 Restricted Stock Incentive Plan and Stock Listing Announcement
June 23, 2026
Notice on Convening the 2nd Extraordinary General Meeting in 2026
June 17, 2026
Announcement on Adjusting the First Grant Price in the 2023 Restricted Stock Incentive Plan
June 3, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 22, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
May 13, 2026
Report for Q1 2026
April 27, 2026
Announcement on Meeting the Vesting Conditions in the 1st Vesting Period for Category I Incentive Objects of Those Initially Granted in the 2023 Restricted Stock Incentive Plan
April 9, 2026
Announcement on Receipt of Performance Commitment Compensation Payments
April 8, 2026
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Wholly-owned Subsidiary
March 18, 2026
2025 Annual Report
March 17, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 26, 2026
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
November 14, 2025
Q3 2025 Continuous Supervision Opinions of China International Capital Corporation Limited on Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd.'s Tender Offer to Acquire Jiangsu HOB Biotech Group Co., Ltd.
November 12, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 6, 2025
Announcement on Resolutions of the 22nd Meeting of the 3rd Board of Supervisors
October 29, 2025
Announcement on Voluntary Disclosure of Signing of Cooperation Framework Agreement and Risk Disclosure
October 21, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
September 25, 2025
Announcement on Progress in Voluntary Disclosure of Phase III Clinical Trial of MM09 Sublingual Spray for Allergy Immunotherapy Completes Enrollment of First Subjects Along with New Business
September 24, 2025
Announcement on Purchasing Liability Insurance for Directors, Supervisors, and Senior Management Members
September 9, 2025
Announcement on Completion of Some Investment Projects Financed by Raised Funds
September 2, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
September 1, 2025
Q2 2025 Continuous Supervision Opinions of China International Capital Corporation Limited on Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd.'s Tender Offer to Acquire Jiangsu HOB Biotech Group Co., Ltd.
August 25, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
August 21, 2025
Announcement on Resolutions of the 19th Meeting of the 3rd Board of Supervisors
August 14, 2025
Announcement on the Sale of Land Use Rights and Plant Buildings
August 4, 2025
Announcement on Vesting Results in the 1st Vesting Period for Category II Incentive Objects of Those Initially Granted in the 2023 Restricted Stock Incentive Plan and Stock Listing Announcement
June 30, 2025
Announcement on Abnormal Fluctuations in Stock Trading
June 12, 2025
Announcement on Resolution of the 18th Meeting of the 3rd Board of Supervisors
June 11, 2025
Announcement on Convening the Q1 2025 Performance Briefing
May 28, 2025
Announcement on Implementation of Dividend Distribution for 2024
May 22, 2025
Announcement on Reply to Letter of Regulation on Information Disclosure of 2024 Annual Report
May 13, 2025
Q1 2025 Continuous Supervision Opinions of China International Capital Corporation Limited on Shuangrun Zhengan Information Consulting (Beijing) Co., Ltd.'s Tender Offer to Acquire Jiangsu HOB Biotech Group Co., Ltd.
May 12, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
May 7, 2025
Report for Q1 2025
April 28, 2025
Announcement on Resignation of Some Directors and Senior Management Members and the By-election of Non-independent Directors
April 16, 2025
Announcement on Meeting the Vesting Conditions in the 1st Vesting Period for Category II Incentive Objects of Those Initially Granted in the 2023 Restricted Stock Incentive Plan
April 9, 2025
Announcement on Resolutions of the 2024 Annual General Meeting
April 7, 2025
Announcement on Change of Financial Advisor in Charge for Continuous Supervision of the Tender Offer by Shuangrun Zheng'an Information Consulting (Beijing) Co., Ltd. to Acquire the Company's Shares
March 28, 2025
Announcement on Resolution of the 18th Meeting of the 3rd Board of Directors
March 17, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 26, 2025
Announcement on Voluntary Disclosure of Wholly-Owned Subsidiaries Obtaining Medical Device Registration Certificates
February 24, 2025